The case concerns the FDA-approved drug Exparel (liposomal bupivacaine), a long-acting local anesthetic used to control post-surgical pain manufactured by Pacira Biosciences, Inc.
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
Stay curious. Stay informed.
Free, independent writing delivered weekly. No ads, no sponsored fluff, and we never share or sell your data.
Join NowAlways free. Never shared.
